Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
基本信息
- 批准号:10475582
- 负责人:
- 金额:$ 35.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAdenovirusesAnti-Inflammatory AgentsAntiinflammatory EffectBlindnessBlood-Retinal BarrierCAV1 geneCaveolaeCell LineCellsComplexConflict (Psychology)DependovirusDevelopmentDiabetic RetinopathyDiseaseDoseEye diseasesFunctional disorderGene TransferGenesGlaucomaGoalsGrowth FactorImmuneIn VitroInfiltrationInflammationInflammatoryInflammatory ResponseInjuryLeadLinkLiteratureMaintenanceMediatingMembraneModelingMorphologyMuller&aposs cellNerve CrushNerve DegenerationNeural RetinaNeurogliaNeuronsOcular PhysiologyOptic NerveOrganPC3 cell linePharmaceutical PreparationsPlayPrimary Open Angle GlaucomaProteinsPublishingRetinaRiskRoleSignal TransductionSteroidsStressStructural ProteinSystemTestingTissuesVirusautoimmune uveitisbasebiological adaptation to stresscaveolin 1cell typechemokinecytokineexperimental studygenetic variantglial activationhuman diseasein vivoinnovationnew therapeutic targetnovelnovel therapeutic interventionprostate cancer cell lineprotein expressionprotein functionpublic health relevanceresponsereverse geneticsscaffoldside effecttherapeutic target
项目摘要
Project summary
Caveolin-1 (Cav1), traditionally viewed as the signature protein of caveolae membrane domains, plays
crucial roles in blood-retinal barrier integrity and retinal inflammation. Gene variants in Cav1 are associated
with risk of primary open angle glaucoma and Cav1 protein expression is upregulated in uveitic retinas and in
models of diabetic retinopathy. We have found that Cav-1 and caveolae play important roles in blood-retinal
barrier (BRB) and inflammation-induced cytokine release. Intriguingly, ablation of Cav1 only from the
neuroretinal compartment (Müller glia and neurons) suppresses cytokine release and immune cell influx
following inflammatory and neurodegenerative insult. As Cav1 is upregulated in several retinal inflammatory
conditions, we hypothesize that local manipulation of Cav1 function presents a viable therapy to suppress
retinal inflammatory stress. Given that current steroid-based therapies for retinal inflammatory disease are not
completely effective and fraught with potentially severe side effects, we hypothesize that Cav1 represents a
novel therapeutic target to suppress retinal inflammation. Thus, it is crucial to understand the function of this
protein in the context of the retinal stress adaptation response. We have made the exciting observation that
Cav1 in Müller glial cells of the neural retina does not reside within traditional, morphologically-identifiable
caveolae. This is because differentiated Müller glia do not normally express significant levels of Cavin1 which,
via interaction with Cav1, is necessary to form caveolae. In all tissues studied to date, loss of Cavin1 results in
coincident loss of Cav1 protein stability. However, in Müller glia, Cav1 is stably expressed (outside of
caveolae) in the absence of Cavin1. This provides a unique opportunity to examine the role of non-caveolar
Cav1 in an organ in which Cav1 is associated with human disease. We hypothesize that this non-caveolar
localization is crucial to Cav1’s ability to promote secretion of cytokines, chemokines, and growth factors. In
this proposal, we will test this novel concept in Müller glia in culture and in vivo by inducing the expression of
Cavin1 to sequester Cav1 within caveolae. We will also take advantage of the unusually stable expression of
Cav1 outside of caveolae to examine the composition of the non-caveolae Cav1 domain (called herein “Cav1
scaffolds”) and to identify the mechanism by which Cav1 is stably expressed without Cavin1. These goals have
clear
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL H ELLIOTT其他文献
MICHAEL H ELLIOTT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL H ELLIOTT', 18)}}的其他基金
Caveolae-based mechanosensors for conventional outflow regulation
用于传统流出调节的基于小凹的机械传感器
- 批准号:
10186755 - 财政年份:2018
- 资助金额:
$ 35.43万 - 项目类别:
Caveolae-based mechanosensors for conventional outflow regulation
用于传统流出调节的基于小凹的机械传感器
- 批准号:
9596193 - 财政年份:2018
- 资助金额:
$ 35.43万 - 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
8963726 - 财政年份:2009
- 资助金额:
$ 35.43万 - 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
10683155 - 财政年份:2009
- 资助金额:
$ 35.43万 - 项目类别:
Role of caveolin-1 in the maintenance of blood-retinal barrier integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
9563983 - 财政年份:2009
- 资助金额:
$ 35.43万 - 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
8580554 - 财政年份:2009
- 资助金额:
$ 35.43万 - 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
7783730 - 财政年份:2009
- 资助金额:
$ 35.43万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 35.43万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 35.43万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 35.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 35.43万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 35.43万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 35.43万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 35.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 35.43万 - 项目类别:
Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 35.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 35.43万 - 项目类别:
Studentship














{{item.name}}会员




